At baseline, CAR28ζ/CPR28 cells were the most effective against HER2+/PD-L1+ U373-GBM cells, but they exhibited the greatest decline in cytotoxic activity following chronic stimulation (two-way ANOVA with the Tukey test; Fig. 3C). Here, CD274 is linked to glioblastoma.